CELLDEX THERAPEUTICS INC (CLDX)       38.81  +1.71 (+4.61%)

38.81  +1.71 (+4.61%)

US15117B2025 - Common Stock - After market: 38.81 0 (0%)

TTM
(2022-9-30)
2021
(2021-12-31)
2020
(2020-12-31)
2019
(2019-12-31)
2018
(2018-12-31)
Revenue
1.08M4.65M7.42M3.57M9.54M
Non Recurring Items
N/A-3.50M-18.00M-1.80M-109.65M
Cost Of Goods
N/AN/AN/AN/AN/A
Gross Profit
N/AN/AN/AN/AN/A
Operating Expenses
93.77M72.39M52.77M56.80M56.32M
Operating Income
N/AN/AN/AN/AN/A
Interest Expense
1.70M505.00K2.41M4.15M4.49M
Income Before Taxes
-105.99M-70.74M-60.95M-50.88M-151.95M
Income Tax
N/A-227.00K-1.17M0.00-770.00K
Net Income
-105.99M-70.51M-59.78M-50.88M-151.18M
EBITDA
N/AN/AN/AN/AN/A
 
Per Share Data
EPS Diluted Total Ops
-2.27-1.64-2.02-3.51-14.48
Non GAAP EPS
-2.08-1.64-2.14-3.63-3.96
 
Statistics
Gross Profit Margin
N/AN/AN/AN/AN/A
Profit Margin
-9831.73%-1516.04%-805.66%-1425.21%-1584.70%
Operating Profit Margin
N/AN/AN/AN/AN/A

All data in USD

Charts